We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cardio3 BioSciences Announces Positive Outcome of the C-Cure® Phase II Clinical Trial in Heart Failure Patients

News   Nov 18, 2010

 
Cardio3 BioSciences Announces Positive Outcome of the C-Cure® Phase II Clinical Trial in Heart Failure Patients
 
 
 

RELATED ARTICLES

Ranitidine Recalled Due to Potential Carcinogen Contamination

News

Teva UK Ltd is recalling unexpired stock of certain batches of two types of Ranitidine medicines – used to treat conditions such as heartburn and stomach ulcers.

READ MORE

Medical Marijuana May Help Lessen Opioid Use and Potential Abuse

News

Medical marijuana shows early promise to lessen opioid use and potential abuse, according to a systematic review of published studies being presented at the ANESTHESIOLOGY® 2019 annual meeting. However, more rigorous scientific research must be conducted to determine if there truly are pain relief benefits to medical marijuana that can help ease chronic pain and outweigh potential risks.

READ MORE

Embryo’s Early Development Revealed in a Dish

News

During embryonic development, the entire nervous system, the skin and the sensory organs emerge from a single sheet of cells known as the ectoderm. While there have been extensive studies of how this sheet forms all these derivatives, it hasn't been possible to study the process in humans - until now.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE